Direct 8(a) award of a 9.5-month base and two 12-month options, labor hour type contract to aneon brillient for the cder for supply chain technical support services

Active Definitive Contract Awarded Last action

Contract number
75F40125C00066
Awardee
Awarding agency
Obligated
$2,653,190

Award facts

Contract value 63% obligated
$4,198,504.44 Current and potential, with all options
Completion date 42% complete
  • Current, with exercised options
  • Potential, with all options
Set-aside
No set-aside
Competition
Not Competed · 1 offer Only One Source
Pricing
Labor Hours
Place of performance
Beltsville, MD 20704, USA
Legislative mandates

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Exercise an Option P00001 $1,500,333
Original award $1,152,858

About this award

The Food and Drug Administration awarded a $4.198 million definitive contract to Aneon Brillient, LLC, an SBA-certified 8(a) joint venture, for supply chain technical support services to the Center for Drug Evaluation and Research (CDER) on August 28, 2025, under a direct 8(a) award.

The contract is a labor-hour type with a 9.5-month base period and two 12-month options, extending through June 15, 2028. Place of performance is Beltsville, Maryland.

Quick answers

Who was awarded contract 75F40125C00066?

75F40125C00066 was awarded to Aneon Brillient, LLC by Food and Drug Administration (Department of Health and Human Services) on August 28, 2025.

How much is contract 75F40125C00066 worth?

The government has obligated $2,653,190 on 75F40125C00066. Its current value, with exercised options, is $4,198,504.

Was contract 75F40125C00066 competed?

The extent of competition for 75F40125C00066 was not competed. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award